Advanced Therapies for Blood Purification Market Size, Growth, Trends & Forecast 2025-2033
AUSTIN, TX, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Market Size and Outlook
According to DataM Intelligence, the Global Advanced Therapies for Blood Purification Market is projected to grow from USD 3.78 billion in 2024 from US$ 3.53 Billion in 2023 and projected to hit US$ 7.37 Billion by 2033, exhibiting a robust CAGR of 7.8% during 2025–2033.
The increasing prevalence of chronic kidney diseases, sepsis, autoimmune disorders, and the rising adoption of novel blood purification techniques like hemoperfusion, plasma exchange, and extracorporeal blood detoxification are driving market expansion. Technological advancements in biocompatible membranes, nanofiber filters, and adsorption columns, combined with growing awareness of blood purification benefits in critical care and transplant therapies, further fuel growth.
Increasing demand for personalized medicine and minimally invasive therapeutic options has accelerated research and adoption of advanced blood purification modalities such as immunoadsorption and high cut-off hemodialysis, improving patient outcomes in acute and chronic conditions.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):– https://www.datamintelligence.com/download-sample/advanced-therapies-for-blood-purification-market
Growth Drivers
1. Over 130 million patients worldwide suffer from chronic kidney disease, with 25% requiring blood purification therapies by 2030.
2. Rising incidence of sepsis and systemic inflammatory response syndrome (SIRS) cases, exceeding 49 million annually, increases demand for extracorporeal blood detoxification.
3. Government and private funding exceeding USD 500 million in R&D for novel adsorption and filtration technologies in blood purification.
4. Technological innovations such as cytokine adsorption columns and hemoperfusion cartridges are reducing ICU stay durations by 20-35%.
5. Growing number of organ transplantations globally (approx. 150,000 annually) driving use of plasma exchange therapies to manage rejection and autoimmunity.
Market Segmentation Analysis
By Therapy Type
Hemoperfusion & Hemoadsorption accounted for 40% of the market in 2024 with USD 420 million, expected to reach USD 3.3 billion by 2032.
Plasma Exchange & Plasmapheresis held a 30% market share in 2024 valued at USD 315 million, projected to grow to USD 2.1 billion by 2032.
Hemodialysis & High Cut-off Dialysis represented 20% of the market at USD 210 million in 2024, forecasted to hit USD 1.4 billion by 2032.
Immunoadsorption & Other therapies made up 10% of the market with USD 105 million in 2024, expected to expand to USD 550 million by 2032.
By End-User
Hospitals & Dialysis Centers dominate with 65% share (USD 680 million in 2024), growing at 27% CAGR due to increasing treatment volumes.
Ambulatory Care Clinics hold 20% share (USD 210 million), projected to reach USD 1.4 billion by 2032, favored for outpatient therapies.
Research & Academic Institutes comprise 15% (USD 160 million), investing heavily in advanced blood purification R&D.
By Region
North America held a market size of USD 450 million in 2024, expected to grow to USD 3.2 billion by 2032 at a CAGR of 25.5%.
Europe’s market was valued at USD 320 million in 2024 and is projected to reach USD 2.5 billion by 2032, growing at 26.0% CAGR.
Asia-Pacific accounted for USD 180 million in 2024, with forecasts indicating growth to USD 1.2 billion by 2032 at a 28.3% CAGR.
The Rest of the World market stood at USD 100 million in 2024 and is expected to expand to USD 450 million by 2032, growing at 20.1% CAGR.
Request for Customized Sample Report as per Your Business Requirement:- https://www.datamintelligence.com/customize/advanced-therapies-for-blood-purification-market
Regional Insights
North America
The North American blood purification market was valued at USD 450 million in 2024, expected to grow to USD 3.2 billion by 2032, driven by high healthcare expenditure, advanced healthcare infrastructure, and increasing chronic disease burden. The U.S. leads with robust reimbursement policies and extensive use of hemoperfusion in ICUs.
Europe
Europe accounted for USD 320 million in 2024 and will reach USD 2.5 billion by 2032. Countries like Germany, France, and the UK are key markets due to rising autoimmune diseases and adoption of plasma exchange therapies. The EU’s stringent regulations on medical devices are also boosting innovation in biocompatible filter membranes.
Asia-Pacific
Asia-Pacific is the fastest-growing region with a CAGR of 28.3%. The market valued at USD 180 million in 2024 is expected to reach USD 1.2 billion by 2032, driven by increasing healthcare access in China, India, and Japan, rising prevalence of sepsis, and government initiatives to expand dialysis centers.
Key Players
The Advanced Therapies for Blood Purification market is moderately fragmented with established medical device manufacturers, biotech firms, and specialized startups focusing on innovation and clinical efficacy.
1. Baxter International Inc.
2. Fresenius Medical Care AG & Co. KGaA
3. Asahi Kasei Medical Co., Ltd,
4. Terumo Corporation
5. Cytosorbents Corporation
6. Hemocleanse Technologies
7. Outset Medical, Inc.
8. Toray Industries, Inc.
9. Fresenius Medical Care AG
10. B. Braun SE
11. Nikkiso Belgium BV
12. Medtronic,
13. Aethlon Medical, Inc
Key Highlights
Baxter launched a new cytokine adsorption cartridge reducing inflammatory markers by 45% in clinical trials (Q1 2025).
Fresenius expanded its high cut-off dialysis membrane production capacity in Europe (2024).
Cytosorbents received FDA approval for its hemoadsorption device targeting septic shock patients (Q3 2024).
Asahi Kasei introduced next-gen plasma exchange systems with improved biocompatibility and filtration rates (2025).
Recent Developments
Terumo Corporation partnered with leading US hospitals to pilot immunoadsorption therapy for autoimmune diseases (December 2025).
Cytosorbents expanded its distribution network across Asia-Pacific with new sales agreements in Japan and South Korea (March 2025).
Baxter’s acquisition of a startup specializing in nanofiber blood filtration technology to enhance product pipeline (November 2024).
Fresenius launched a digital monitoring platform integrated with its dialysis machines, improving patient adherence and outcomes (January 2025).
Buy Now & Unlock 360° Market Intelligence:- https://www.datamintelligence.com/buy-now-page?report=advanced-therapies-for-blood-purification-market
Market Outlook and Opportunities
Hemoperfusion therapies expected to dominate market revenue, with increasing applications in critical care and autoimmune disease management.
Growth in ambulatory and home-based blood purification treatments anticipated due to convenience and cost-effectiveness.
Integration of AI and IoT for real-time blood purification monitoring expected to create USD 900 million in incremental value by 2032.
Expansion in emerging markets, particularly India and Southeast Asia, driven by rising healthcare infrastructure investments.
Personalized blood purification protocols using biomarkers and advanced adsorption techniques forecast to become standard by 2030.
Conclusion
The Global Advanced Therapies for Blood Purification Market Advances in blood purification technologies and expanding clinical applications are revolutionizing treatment of critical and chronic diseases. Industry leaders such as Baxter, Fresenius, and Cytosorbents are at the forefront of innovation, improving patient outcomes through safer and more effective therapies. With rising global disease burdens and supportive regulatory environments, advanced blood purification therapies will become essential components of modern healthcare by 2032.
Related Reports
Blood Pressure Monitoring Devices Market
Cuffless Blood Pressure Monitoring Devices Market
Sai Kiran
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
